Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis
Paola Guglielmelli(Tumour Institute of Tuscany)
Cited by 149
Related Papers
No related papers found
Powered by citation graph analysis